Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
Medical Developments International Community
ASX:MVP Community
1
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Create a narrative
Medical Developments International
Popular
Undervalued
Overvalued
Community Investing Ideas
Medical Developments International
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Targeted Pricing And Penthrox Expansion Will Broaden International Reach
Key Takeaways Targeted pricing and efficiency programs are improving margins, expected to enhance earnings and net margins over the next few years. Growth in Penthrox volumes, regulatory approvals, and partner-supported models aim to boost revenue in key markets.
View narrative
AU$2.31
FV
74.2% undervalued
intrinsic discount
14.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
MVP
MVP
Medical Developments International
Your Fair Value
AU$
Current Price
AU$0.59
38.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-30m
72m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$72.5m
Earnings AU$10.7m
Advanced
Set Fair Value